Celltrion announced on June 26 that its board of directors has approved an additional repurchase of treasury shares worth approximately KRW 100 billion (USD 72 million). The repurchase will be carried out through on-market purchases beginning June 27.
The company stated that this decision is part of its continued efforts to enhance shareholder value and reflects its confidence in long-term growth. Including this latest move, Celltrion has conducted seven treasury share buybacks so far this year, totaling approximately KRW 650 billion (USD 470 million).
In April, Chairman Seo Jung-jin of Celltrion Group, the holding company Celltrion Holdings, and affiliate Celltrion Skincure respectively decided to acquire KRW 50 billion (USD 36 million), KRW 100 billion (USD 72 million), and KRW 50 billion (USD 36 million) worth of shares. Employees also actively participated, purchasing about KRW 40 billion (USD 29 million) through the employee stock ownership plan.
Celltrion emphasized that this company-wide initiative reflects the strong confidence of executives and employees in the company’s intrinsic value and growth potential, while reinforcing its commitment to maximizing shareholder returns.
Last month, the company issued 8,494,384 bonus shares by allocating 0.04 new shares for each common share held as part of its shareholder return program. On May 21, Celltrion also canceled approximately KRW 100 billion (USD 72 million) worth of treasury shares, and is pursuing additional cancellations worth around KRW 900 billion (USD 650 million) throughout this year.
Amid continued internal and external uncertainties, Celltrion stated that its intrinsic value remains significantly undervalued and that it will continue to implement measures to boost market confidence and enhance shareholder value.
